Point-of-care testing reaches those at risk, eliminating need for follow up.
Rapid results mean you can educate and begin intervention immediately, while parents are still in your clinic. LeadCare II’s accurate result empowers parents and communities to act without delay.
Over 535,000 children in the U.S. have harmful blood lead levels.2 Have these children in your community been identified?
Who should be tested?
Federal law requires that all Medicaid eligible children be tested at 12 and 24 months and ages 36 to 72 months if they have not previously been tested.
Each state has guidelines for blood lead testing. The American Academy of Pediatrics (AAP) recommends that “children should be tested at least once when they are 2 years of age or, ideally, twice, at 1 and 2 years of age, unless lead exposure can be confidently excluded.3
Who is at risk for lead exposure? Children are considered at risk if any of the following are true4:
Child lives in or frequently visits a home built before 1950, or a recently renovated home built before 1978.
Child has a sibling or frequent playmate with elevated blood lead levels.
Child’s parent or primary caregiver works with lead. Examples include: battery recycling or manufacture, lead smelting, lead mining, auto repair, shipbuilding, construction, plumbing, and glass manufacture.5
Child is a recent immigrant, refugee, or foreign adoptee.
Child has a household member who uses traditional, folk, or ethnic remedies or cosmetics or who routinely eats food imported informally (e.g., by a family member).
The LeadCare II System was developed with the Centers for Disease Control and Prevention (CDC) so children can be screened for lead wherever they already receive healthcare or services. It is the only CLIA-waived point-of-care blood lead testing system.
Accurate, early diagnosis is crucial so that children can be treated to prevent serious health and learning consequences. Blood lead testing also guides lead remediation and enforcement actions to eliminate lead contamination in housing, consumer products, and the environment.
No safe levels. Evidence continues to grow that even low blood lead levels may affect learning. Elevated blood lead levels have been associated with avoidable special education costs of $3,331 per child and a decrease in lifetime earnings.6
To learn more or to discuss how LeadCare II can help you improve screening rates in the communities you serve, contact us.